Long-term Safety of Oral Systemic Therapies for Psoriasis: A Comprehensive Review of the Literature
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long-term Safety of Oral Systemic Therapies for Psoriasis: A Comprehensive Review of the Literature
Authors
Keywords
-
Journal
Dermatology and Therapy
Volume 10, Issue 4, Pages 589-613
Publisher
Springer Science and Business Media LLC
Online
2020-06-11
DOI
10.1007/s13555-020-00409-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety considerations with combination therapies for psoriasis
- (2020) Mio Nakamura et al. Expert Opinion On Drug Safety
- A safety evaluation of dimethyl fumarate in moderate-to-severe psoriasis
- (2020) Radomir Reszke et al. Expert Opinion On Drug Safety
- JOINT AAD-NPF GUIDELINES OF CARE FOR THE MANAGEMENT OF PSORIASIS WITH SYSTEMIC NON-BIOLOGICAL THERAPIES
- (2020) Alan Menter et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Re-Categorization of Psoriasis Severity: Delphi Consensus from the International Psoriasis Council
- (2019) Bruce Strober et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- An observer-blinded randomized controlled pilot trial comparing localized immersion psoralen-ultraviolet A with localized narrowband ultraviolet B for the treatment of palmar hand eczema
- (2018) D. Brass et al. BRITISH JOURNAL OF DERMATOLOGY
- A review of the mechanisms of action of dimethylfumarate in the treatment of psoriasis
- (2018) Jürgen Brück et al. EXPERIMENTAL DERMATOLOGY
- Reply to comment on “Drug survival of apremilast for psoriasis in a real-world setting”
- (2018) Erica B. Lee et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Drug survival of apremilast for psoriasis in a real-world setting
- (2018) Erica B. Lee et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Low drug survival of apremilast for psoriasis in a real-word-setting
- (2018) Jorge Santos-Juanes et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Short-term reasons for withdrawal and adverse events associated with apremilast therapy for psoriasis in real-world practice compared with in clinical trials: A multicenter retrospective study
- (2018) Arvin Ighani et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Long-term real-life safety profile and effectiveness of fumaric acid esters in psoriasis patients: a single-centre, retrospective, observational study
- (2018) H. Dickel et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Real-world data on the efficacy and safety of apremilast in patients with moderate-to-severe plaque psoriasis
- (2018) E. Papadavid et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Dermatological guidelines for monitoring methotrexate treatment reduce drug-survival compared to rheumatological guidelines
- (2018) Felien T. M. Busger op Vollenbroek et al. PLoS One
- The Pharmacokinetics of Fumaric Acid Esters Reveal Their In Vivo Effects
- (2018) Ulrich Mrowietz et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Update on subcutaneous methotrexate for inflammatory arthritis and psoriasis
- (2018) Gino A Vena et al. Therapeutics and Clinical Risk Management
- Review of safety and efficacy of approved systemic psoriasis therapies
- (2018) Shivani B. Kaushik et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Clinical use of dimethyl fumarate in moderate-to-severe plaque-type psoriasis: a European expert consensus
- (2018) U. Mrowietz et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Methotrexate-induced pancytopenia: a case series of 46 patients
- (2017) Sajal Ajmani et al. International Journal of Rheumatic Diseases
- 014 Apremilast in psoriasis - a prospective real-world study
- (2017) I. Vujic et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Infections in Moderate to Severe Psoriasis Patients Treated with Biological Drugs Compared to Classic Systemic Drugs: Findings from the BIOBADADERM Registry
- (2017) Paula Dávila-Seijo et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Progressive multifocal leukoencephalopathy in patients treated with fumaric acid esters: a review of 19 cases
- (2017) Robbert-Jan Gieselbach et al. JOURNAL OF NEUROLOGY
- Long-term safety and tolerability of apremilast in patients with psoriasis: Pooled safety analysis for ≥156 weeks from 2 phase 3, randomized, controlled trials (ESTEEM 1 and 2)
- (2017) Jeffrey Crowley et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Apremilast in psoriasis - a prospective real-world study
- (2017) I. Vujic et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- European S3-Guideline on the systemic treatment of psoriasis vulgaris - Update Apremilast and Secukinumab - EDF in cooperation with EADV and IPC
- (2017) A. Nast et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- An intensified dosing schedule of subcutaneous methotrexate in patients with moderate to severe plaque-type psoriasis (METOP): a 52 week, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Richard B Warren et al. LANCET
- Efficacy and safety of LAS41008 (dimethyl fumarate) in adults with moderate-to-severe chronic plaque psoriasis: a randomized, double-blind, Fumaderm® - and placebo-controlled trial (BRIDGE)
- (2016) U. Mrowietz et al. BRITISH JOURNAL OF DERMATOLOGY
- British Association of Dermatologists’ guidelines for the safe and effective prescribing of methotrexate for skin disease 2016
- (2016) R.B. Warren et al. BRITISH JOURNAL OF DERMATOLOGY
- Efficacy and Survival of Systemic Psoriasis Treatments: An Analysis of the Swiss Registry SDNTT
- (2016) Julia-Tatjana Maul et al. DERMATOLOGY
- Fumaric acid esters for psoriasis: a systematic review
- (2016) D. Smith IRISH JOURNAL OF MEDICAL SCIENCE
- Drug survival rates and reasons for drug discontinuation in psoriasis
- (2016) Tobias Arnold et al. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
- Real-World Experience With Apremilast in Treating Psoriasis
- (2016) Julia N. Mayba et al. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY
- The efficacy and safety of apremilast, etanercept and placebo in patients with moderate-to-severe plaque psoriasis: 52-week results from a phase IIIb, randomized, placebo-controlled trial (LIBERATE)
- (2016) K. Reich et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Safety and Efficacy of Methotrexate in Psoriasis: A Meta-Analysis of Published Trials
- (2016) Jonathan West et al. PLoS One
- Factors Associated with Drug Survival of Methotrexate and Acitretin in Patients with Psoriasis
- (2015) G Shalom et al. ACTA DERMATO-VENEREOLOGICA
- Selective Phosphodiesterase Inhibitors for Psoriasis: Focus on Apremilast
- (2015) Melinda Gooderham et al. BIODRUGS
- Demographics and disease characteristics of patients with psoriasis enrolled in the British Association of Dermatologists Biologic Interventions Register
- (2015) I.Y.K. Iskandar et al. BRITISH JOURNAL OF DERMATOLOGY
- Apremilast: A Review in Psoriasis and Psoriatic Arthritis
- (2015) Emma D. Deeks DRUGS
- Long-term safety and effectiveness of high-dose dimethylfumarate in the treatment of moderate to severe psoriasis: a prospective single-blinded follow-up study
- (2015) Raphaël Lijnen et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1)
- (2015) Kim Papp et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- European S3-Guidelines on the systemic treatment of psoriasis vulgaris - Update 2015 - Short version - EDF in cooperation with EADV and IPC
- (2015) A. Nast et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Combining Biologic Therapies With Other Systemic Treatments in Psoriasis
- (2015) April W. Armstrong et al. JAMA Dermatology
- Drug survival of fumaric acid esters for psoriasis: a retrospective study
- (2014) N. Ismail et al. BRITISH JOURNAL OF DERMATOLOGY
- Methotrexate: an old new drug in autoimmune disease
- (2014) Paola Cipriani et al. Expert Review of Clinical Immunology
- Methotrexate-Induced Liver Toxicity
- (2014) Bruce E. Strober JAMA Dermatology
- Combination Therapy in Psoriasis
- (2012) Cheryl J. Gustafson et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Systematic Review and Meta-Analysis of Methotrexate Use and Risk of Cardiovascular Disease
- (2011) Renata Micha et al. AMERICAN JOURNAL OF CARDIOLOGY
- The use of methotrexate in dermatology: a review
- (2011) Sarah Shen et al. AUSTRALASIAN JOURNAL OF DERMATOLOGY
- Guidelines of care for the management of psoriasis and psoriatic arthritis
- (2011) Alan Menter et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Oral cyclosporin in psoriasis: a systematic review on treatment modalities, risk of kidney toxicity and evidence for use in non-plaque psoriasis
- (2011) A Maza et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- The use of cyclosporine in dermatology: Part II
- (2010) Caitriona Ryan et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Assessment and management of methotrexate hepatotoxicity in psoriasis patients: report from a consensus conference to evaluate current practice and identify key questions toward optimizing methotrexate use in the clinic
- (2010) J. Barker et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Malignancy concerns with psoriasis treatments using phototherapy, methotrexate, cyclosporin, and biologics: facts and controversies
- (2009) Luigi Naldi CLINICS IN DERMATOLOGY
- Methotrexate: Understanding the risk in psoriasis patients
- (2009) Jennifer Lucas et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Guidelines of care for the management of psoriasis and psoriatic arthritis
- (2009) Alan Menter et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference
- (2009) Robert E. Kalb et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- European S3-Guidelines on the systemic treatment of psoriasis vulgaris
- (2009) D Pathirana et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More